D N Gerding
Overview
Explore the profile of D N Gerding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
3947
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Snydman D, McDermott L, Thorpe C, Goldstein E, Schuetz A, Johnson S, et al.
Antimicrob Agents Chemother
. 2023 Sep;
67(10):e0034923.
PMID: 37728368
We have previously reported on the susceptibility and epidemiology of isolates from six geographically dispersed medical centers in the United States. This current survey was conducted with isolates collected in...
2.
Snydman D, McDermott L, Jenkins S, Goldstein E, Patel R, Forbes B, et al.
Anaerobe
. 2020 May;
63:102185.
PMID: 32387171
Background: Geographic and temporal trends in the distribution of PCR ribotypes for Clostridioides difficile associated diarrheal isolates obtained in the United States (US) are changing. As part of a US...
3.
Thorpe C, McDermott L, Tran M, Chang J, Jenkins S, Goldstein E, et al.
Antimicrob Agents Chemother
. 2019 May;
63(7).
PMID: 31085514
In 2011, we initiated a sentinel surveillance network to assess changes in (formerly ) antimicrobial susceptibility to fidaxomicin from 6 geographically dispersed medical centers in the United States. This report...
4.
Cairns M, Preston M, Hall C, Gerding D, Hawkey P, Kato H, et al.
J Clin Microbiol
. 2017 May;
55(6):1971.
PMID: 28536162
No abstract available.
5.
Cairns M, Preston M, Hall C, Gerding D, Hawkey P, Kato H, et al.
J Clin Microbiol
. 2016 Dec;
55(3):865-876.
PMID: 28031436
The diarrheal pathogen consists of at least six distinct evolutionary lineages. The RT017 lineage is anomalous, as strains only express toxin B, compared to strains from other lineages that produce...
6.
7.
Gerding D, Hecht D, Louie T, Nord C, Talbot G, Cornely O, et al.
J Antimicrob Chemother
. 2015 Oct;
71(1):213-9.
PMID: 26433782
Objectives: The aim of this study was to evaluate the susceptibilities of Clostridium difficile isolates to cadazolid, a novel antibiotic for the treatment of C. difficile infection. Methods: Ribotyping and...
8.
Snydman D, McDermott L, Jacobus N, Thorpe C, Stone S, Jenkins S, et al.
Antimicrob Agents Chemother
. 2015 Aug;
59(10):6437-43.
PMID: 26239985
In 2011 a surveillance study for the susceptibility to fidaxomicin and epidemiology of Clostridium difficile isolates in the United States was undertaken in seven geographically dispersed medical centers. This report...
9.
Price J, Cheek E, Lippett S, Cubbon M, Gerding D, Sambol S, et al.
Clin Microbiol Infect
. 2009 Oct;
16(8):1297-302.
PMID: 19832710
Strategies to reduce rates of Clostridium difficile infection (CDI) generally recommend isolation or cohorting of active cases and the reduced use of cephalosporin and quinolone antibiotics. Data supporting these recommendations...
10.
Citron D, Babakhani F, Goldstein E, Nagaro K, Sambol S, Sears P, et al.
Anaerobe
. 2009 Sep;
15(6):234-6.
PMID: 19755166
Background: Clostridium difficile infection (CDI) has been increasing in incidence and severity in recent years, coincident with the spread of a "hypervirulent" strain, REA type BI (ribotype 027, PFGE NAP...